Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-06-30 to 2025-07-01
Current total value of award: $746.82
Description: 4568678613!QUILLIVANT XR 25 MG/5 ML SUSP 120ML